AMLX ▲ +2.6% - Amylyx Pharmaceuticals, Inc. $AMLX Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting 06-OCT-2026 08:04 AM ET